scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PLoSO...747134D |
P356 | DOI | 10.1371/JOURNAL.PONE.0047134 |
P932 | PMC publication ID | 3469549 |
P698 | PubMed publication ID | 23071737 |
P5875 | ResearchGate publication ID | 232257369 |
P50 | author | Clemens Löwik | Q50637462 |
J Wouter Jukema | Q64858750 | ||
P2093 | author name string | Paul H A Quax | |
Margreet R de Vries | |||
Hans W M Niessen | |||
Jaap F Hamming | |||
P2860 | cites work | Structure and function of matrix metalloproteinases and TIMPs | Q30014818 |
Hemostasis in the mouse (Mus musculus): a review. | Q33537935 | ||
Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications | Q33712421 | ||
Effect of matrix metalloproteinase-9 knockout on vein graft remodelling in mice | Q34051151 | ||
Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries | Q34098485 | ||
Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice | Q34236802 | ||
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 | ||
Vulnerable plaque: the pathology of unstable coronary lesions | Q35022876 | ||
Rapid development of vein graft atheroma in ApoE-deficient mice | Q35745654 | ||
Mouse model of venous bypass graft arteriosclerosis | Q35753478 | ||
Pericellular proteases in angiogenesis and vasculogenesis | Q36392557 | ||
Assessment of unstable atherosclerosis in mice | Q36749103 | ||
Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. | Q37373638 | ||
Role of hemodynamic shear stress in cardiovascular disease | Q37802519 | ||
A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease. | Q39690874 | ||
Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death | Q40993289 | ||
Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention | Q41729196 | ||
Inhibition of intimal hyperplasia by the tetracycline derived mmp inhibitor doxycycline in vein graft disease in vitro and in vivo | Q43275722 | ||
Intraplaque hemorrhage and progression of coronary atheroma | Q44688413 | ||
Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3. | Q45858376 | ||
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth | Q45873353 | ||
Matrix-metalloproteinase-14 deficiency in bone-marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques | Q46771682 | ||
Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE*3Leiden mice. | Q51769531 | ||
Multimodality imaging reveals a gradual increase in matrix metalloproteinase activity at aneurysmal lesions in live fibulin-4 mice. | Q53287414 | ||
Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. | Q54092409 | ||
Accelerated atherosclerosis and calcification in vein grafts: a study in APOE*3 Leiden transgenic mice. | Q55036145 | ||
In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteina | Q55052486 | ||
Role of inflammation and metalloproteinases in plaque disruption and thrombosis | Q57133777 | ||
Short Communication: The Neuropeptide Substance P Mediates Adventitial Mast Cell Activation and Induces Intraplaque Hemorrhage in Advanced Atherosclerosis | Q63258306 | ||
Annexin A5 Therapy Attenuates Vascular Inflammation and Remodeling and Improves Endothelial Function in Mice | Q63915483 | ||
Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis | Q64377816 | ||
Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model | Q64379606 | ||
Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice | Q64381373 | ||
Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U) | Q73690447 | ||
Putative murine models of plaque rupture | Q80006575 | ||
Defining and defending murine models of plaque rupture | Q80006585 | ||
Inflammation and atherosclerosis | Q80015206 | ||
Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques | Q81362707 | ||
Pathology of the vulnerable plaque | Q83187650 | ||
Platelets enter atherosclerotic plaque via intraplaque microvascular leakage and intraplaque hemorrhage: a histopathological study in carotid plaques | Q83875437 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | atherosclerosis | Q12252367 |
overexpression | Q61643320 | ||
P304 | page(s) | e47134 | |
P577 | publication date | 2012-10-11 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Plaque rupture complications in murine atherosclerotic vein grafts can be prevented by TIMP-1 overexpression | |
P478 | volume | 7 |
Q59359696 | Adeno-Associated Virus-Mediated Gene Transfer of Tissue Inhibitor of Metalloproteinases-1 Impairs Neutrophil Extracellular Trap Formation and Ameliorates Hepatic Ischemia and Reperfusion Injury |
Q33690385 | Biglycan and decorin differentially regulate signaling in the fetal membranes |
Q59313996 | Blockade of vascular endothelial growth factor receptor 2 inhibits intraplaque haemorrhage by normalization of plaque neovessels |
Q43033776 | Complement factor C5a induces atherosclerotic plaque disruptions |
Q41579824 | Deficiency of TLR4 homologue RP105 aggravates outward remodeling in a murine model of arteriovenous fistula failure. |
Q39940427 | Deficiency of the TLR4 analogue RP105 aggravates vein graft disease by inducing a pro-inflammatory response |
Q34199412 | Effects of reduced β2-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice |
Q92751623 | Hypercholesterolemia affects cardiac function, infarct size and inflammation in APOE*3-Leiden mice following myocardial ischemia-reperfusion injury |
Q50127096 | Inflammation in Vein Graft Disease. |
Q58698811 | Internal Bleeding: Is Intraplaque Hemorrhage a Decoration or a Driver? |
Q38826454 | Intraplaque neovascularization as a novel therapeutic target in advanced atherosclerosis |
Q37213317 | Macrophage Notch Ligand Delta-Like 4 Promotes Vein Graft Lesion Development: Implications for the Treatment of Vein Graft Failure |
Q89551999 | Prolonged Hyperoxygenation Treatment Improves Vein Graft Patency and Decreases Macrophage Content in Atherosclerotic Lesions in ApoE3*Leiden Mice |
Q38578275 | Prospect and progress of gene therapy in treating atherosclerosis |
Q55087013 | Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease. |
Q38837879 | Vein graft failure: from pathophysiology to clinical outcomes. |
Q100385947 | bFGF blockade reduces intraplaque angiogenesis and macrophage infiltration in atherosclerotic vein graft lesions in ApoE3*Leiden mice |
Q92802274 | miRMap: Profiling 14q32 microRNA Expression and DNA Methylation Throughout the Human Vasculature |
Search more.